Summit Therapeutics
SMMT
#1490
Rank
C$20.37 B
Marketcap
C$27.37
Share price
4.51%
Change (1 day)
4.51%
Change (1 year)

Market capitalization of Summit Therapeutics (SMMT)

Market cap: C$20.37 Billion

As of January 2026 Summit Therapeutics has a market cap of C$20.37 Billion. This makes Summit Therapeutics the world's 1490th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Summit Therapeutics from 2015 to 2026

End of year Market Cap

Year Marketcap Change
2026C$20.37 B10.19%
2025C$18.49 B-4.03%
2024C$19.27 B694.27%
2023C$2.42 B108.97%
2022C$1.16 B246.59%
2021C$0.33 B-32.05%
2020C$0.49 B251.16%
2019C$0.14 B444.66%
2018C$25.77 M-87.6%
2017C$0.20 B46.99%
2016C$0.14 B-27.66%
2015C$0.19 B

End of Day market cap according to different sources

On Jan 11th, 2026 the market cap of Summit Therapeutics was reported to be:

C$20.37 Billion
by Nasdaq info icon info icon
C$20.37 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sarepta Therapeutics
SRPT
C$3.47 B-82.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
C$8.57 B-57.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
C$0.31 B-98.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Coherus BioSciences
CHRS
C$0.28 B-98.61%๐Ÿ‡บ๐Ÿ‡ธ USA